Albany Molecular Research (AMRI)

Albany Molecular Research (AMRI) Overview

Founded in 1991, AMRI (NASDAQ: AMRI) provides scientific services, products and technologies that improve quality of life while delivering excellence, value and maximum return. AMRI’s core business consists of a fee-for-service contract services platform encompassing drug discovery, development and manufacturing services, and a separate, strategic technology division consisting of proprietary technology investments, internal drug discovery and niche generic active pharmaceutical ingredient product development.

The AMRI Advantage:

Experience:

Using excellence as the standard by which we measure success, AMRI’s commitment to quality has been the cornerstone of our business for almost 20 years. Our strategy of providing innovative drug discovery, development and manufacturing while striving for high quality service, attention to detail, and continuous improvement set AMRI apart from the competition.

Through internal research projects and collaborations with various partners, AMRI has conducted and is continuing to conduct important studies on new treatments for cystic fibrosis, Huntington’s disease, Alzheimer’s disease, cancer, obesity, infectious diseases, spinal muscular atrophy and a variety of other medical conditions. Over 1300 of AMRI’s well trained employees have demonstrated a successful history with more than 750 R&D programs, 45 APIs in Phase I and II, 13 APIs in Phase III and 25 commercial APIs being completed.
Quality Service:
AMRI has a reputation for its excellent service and offers a global network of research and manufacturing facilities and is therefore uniquely positioned in the marketplace to provide a competitive advantage to a diverse group of customers. Our presence in the global pharmaceutical community combined with the variety of services that AMRI facilities provide in the USA, Hungary, Singapore, and India have enables AMRI to serve our consumers on a larger scale.

Variety of Services:

AMRI provides a broad spectrum of services backed by a highly experienced and educated and scientific staff. These services can be accessed independently or integrated into a full drug discovery, development and manufacturing platform.

Our comprehensive suite of services allows our customers to contract with a single partner, eliminating the time and cost of transitioning projects among multiple vendors. These services include:

Discovery

At the earliest stag¬es of drug discovery, AMRI helps customers identify and optimize biologically active compounds using a variety of methods. Once a lead compound is identified, AMRI provides medicinal chemistry lead opti¬mization. Specific areas of expertise include:

• Libraries
• Natural Product Technologies
• Assay Development
• Reagent Production Screening
• Fermentation
• Parallel Chemistry
• Biocatalysis
• CADD
• In vitro ADME/Tox
• Scaffold Synthesis
• Derivatization

Development/Small Scale Manufacturing

AMRI provides a variety of key development services to help move compounds into clinical trials including:

• Chemical process R&D
• Preformulation
• Formulation development • Analytical development
• Separation sciences
• Bioanalytical services


Additionally, AMRI can scale-up compounds for preclinical testing, as well as develop new synthetic routes to target compounds.

Large Scale Manufacturing

Our large scale facilities provide manufacturing of active pharmaceutical ingredients (API), advanced intermediates, and a number of high quality generic APIs.

With our U.S.-based commercial cGMP facility, we manufacture customer compounds for both clinical trials and commercial products and provide specialized capabili¬ties in the areas of high potency and controlled substance manufacturing. Additionally, our production facilities in Asia provide a reliable and cost-effective supply chain of non-GMP intermediates for our U.S. facility.


Excellent Communication and Project Management:

At AMRI we continuously strive to provide high quality and efficient customer service. Project Management facilitates the level of service we hope to attain by assigning a project manager to oversee the process of each endeavor from start to finish; ensuring consistency and clear communication.

AMRI’s Project managers are well trained process chemists/engineers with extensive experience in scale up of APIs from early development through commercial manufacturing, and therefore are well equipped to lead projects that may require services from more than one of our locations.


A Growing Market:

AMRI provides contract services to many of the world’s leading companies in the pharmaceutical, biotechnology, medical, cosmetic and food industries, as well as not-for-profit organizations, educational institutions and others.
Over the past several years, through a combination of acquisitions and greenfield startups, AMRI has expanded its global footprint to include large scale manufacturing facilities in India and research facilities in Hungary, Singapore and India, allowing AMRI to provide customers with the excellent service and competitive cost structures to meet individual outsourcing needs.